Literature DB >> 6863454

Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids.

M L Blank, F Snyder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6863454     DOI： 10.1016/s0378-4347(00)80963-9

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  20 in total

1.  Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.

Authors:  T R Martin; G Raugi; T L Merritt; W R Henderson
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Determination of platelet-activating factor by a chemiluminescence method and its application to stimulated guinea pig neutrophils.

Authors:  Y Hasegawa; E Kunow; J Shindou; H Yuki
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis.

Authors:  S Fernández-Gallardo; M A Gijón; C García; V Furio; F T Liu; M Sánchez Crespo
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

4.  Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes.

Authors:  F Malavasi; C Tetta; A Funaro; G Bellone; E Ferrero; A C Franzone; P Dellabona; R Rusci; L Matera; G Camussi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.

Authors:  T M McIntyre; G A Zimmerman; K Satoh; S M Prescott
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor-alpha (TNF-alpha), platelet-activating factor (PAF) and FN in proliferative glomerulonephritis.

Authors:  A Ortíz; J Alonso; M Gómez-Chiarri; J L Lerma; D Seron; E Condom; E González; J Egido
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

7.  Metabolism of platelet-activating factor in human haematopoietic cell lines. Differences between myeloid and lymphoid cells.

Authors:  M C Garcia; C Garcia; M A Gijon; S Fernandez-Gallardo; F Mollinedo; M Sanchez Crespo
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

8.  Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists.

Authors:  F Cabré; D Tost; N Suesa; M Gutiérrez; P Ucedo; D Mauleón; G Carganico
Journal:  Agents Actions       Date:  1993-03

9.  Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin.

Authors:  S M Prescott; G A Zimmerman; T M McIntyre
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis.

Authors:  E González; C de la Cruz; R de Nicoläs; J Egido; G Herrero-Beaumont
Journal:  Agents Actions       Date:  1994-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.